Get the Stockscreener App
1.98
2.94%
-0.06
Jaguar Health Inc stock is traded at $1.98, with a volume of 41,171.
It is down -2.94% in the last 24 hours and down -20.80% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$2.04
Open:
$2
24h Volume:
41,171
Relative Volume:
0.41
Market Cap:
$3.79M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.1223
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
-11.61%
1M Performance:
-20.80%
6M Performance:
-91.04%
1Y Performance:
-93.34%
1-Day Range:
$1.9301
$2.01
1-Week Range:
$1.9301
$2.27
52-Week Range:
$1.9301
$35.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.98 | 3.33M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
How volatile is Jaguar Health Inc. stock compared to the marketPost Market Target Finder For Every Investor - jammulinksnews.com
why is JAGX "Revenue Below Expectations" - AInvest
When is Jaguar Health Inc. stock expected to show significant growthFree Stock Recommendation With Proven Results - jammulinksnews.com
Is Jaguar Health Inc. a growth stock or a value stockRetirement Planning Target Finder Backed By Experts - jammulinksnews.com
What makes Jaguar Health Inc. stock price move sharplySmart Money Tracking Signal Generator Activated - metal.it
Can JAGX sustain its Q4 2024 earnings momentum? - AInvest
How did JAGX's Q4 2024 earnings surprise investors? - AInvest
How did JAGX's revenue and expenses shift in Q4 2024? - AInvest
What risks could impact Jaguar Health Inc. stock performanceTriple Digit Return Stock Predictions Released - metal.it
What is the risk reward ratio of investing in Jaguar Health Inc. stockRapid market gains - jammulinksnews.com
Does Jaguar Health Inc. stock perform well during market downturnsUnlock powerful investment tools for free - jammulinksnews.com
Should I hold or sell Jaguar Health Inc. stock in 2025Accelerate your capital gains today - jammulinksnews.com
What catalysts could drive Jaguar Health Inc. stock higher in 2025Free Consultation - jammulinksnews.com
What is Jaguar Health Inc. company’s growth strategyGet real-time alerts on top-performing stocks - jammulinksnews.com
What are the technical indicators suggesting about Jaguar Health Inc.High-margin investment plays - jammulinksnews.com
How many analysts rate Jaguar Health Inc. as a “Buy”Build wealth faster with consistent investment plans - jammulinksnews.com
What are Jaguar Health Inc. company’s key revenue driversStrongest growth potential - jammulinksnews.com
How does Jaguar Health Inc. compare to its industry peersConsistent high-yield stocks - jammulinksnews.com
What are the latest earnings results for Jaguar Health Inc.Get high-impact stock recommendations now - jammulinksnews.com
Is Jaguar Health Inc. a good long term investmentConsistent triple-digit returns - PrintWeekIndia
What drives Jaguar Health Inc. stock priceDouble-digit growth - Autocar Professional
What analysts say about Jaguar Health Inc. stockBreakout profit opportunities - PrintWeekIndia
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Sentinel-Standard
Jaguar Health Inc. Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):